Arash Babaei-Ghazani, MD

Role in study: First author, Study 12 -- "Continuous Shortwave Diathermy with Exercise Reduces Pain and Improves Function in Lateral Epicondylitis More Than Sham Diathermy: A Randomized Controlled Trial" (Journal of Bodywork & Movement Therapies, 2020; PMID 31987565)

Verification date: 2026-09-18

Career

Dr. Babaei-Ghazani is an Associate Professor of Physical Medicine and Rehabilitation at Iran University of Medical Sciences, Tehran, where he has served in the Neuromusculoskeletal Research Center since 2014.
His training spans Tabriz University of Medical Sciences, where he completed his general medical degree (2001-2008) and his specialty in physical medicine and rehabilitation (2010-2013), and the University of Montreal, where he completed a fellowship in musculoskeletal ultrasound and fluoroscopic guided spine interventions (2020-2021).
His 53 PubMed records, from 2012 to the present, form a single continuous body of musculoskeletal medicine at Iran University of Medical Sciences, with a University of Montreal health-center author block during the fellowship year.

Research Work

Dr. Babaei-Ghazani's research spans ultrasound-guided injections, electrodiagnostics, diathermy, prolotherapy, SONK, and neuro-rehabilitation: 53 PubMed records, 2012-2026, in one continuous musculoskeletal class.
His ORCID record carries 42 works including Study 12 itself.
He is first author of Study 12, a randomized placebo-controlled trial in which adding continuous shortwave diathermy to a specific exercise regimen reduced pain and improved function in chronic lateral epicondylitis more than sham diathermy and exercise (50 patients, intention-to-treat analysis, outcomes at baseline, sessions 5 and 10, and 3 months).

Role in Study 12

First author of Study 12. See Study 12: Shortwave Diathermy Enhances Recovery in Lateral Epicondylitis (Journal of Bodywork & Movement Therapies, 2020; PMID 31987565).

Identifiers

ORCID: 0000-0003-3874-9298

Relationship statement: King Brand utilized the individual's work in the development of our products and treatments. The study and all the professional's work was independent of King Brand - they did not work for us, nor were they compensated by us - it is truly independent. King Brand has relied on the results of this study, this individual's work, and the work and studies of others in the development of our medical solutions.

Sources

ORCID public record 0000-0003-3874-9298 · PubMed author class (Babaei-Ghazani A) · Verbatim Assistant Professor byline (PMID 27683642) · Study 12 on PubMed (PMID 31987565)

Profile verified as of 2026-09-18; annual re-verification scheduled.

← All honored medical professionals and researchers · Study 12 →